Page last updated: 2024-08-24

oseltamivir and Breast Neoplasms

oseltamivir has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Burov, SV; Haq, S; Harless, W; Markvicheva, E; Qorri, B; Sambi, M; Samuel, V; Szewczuk, MR	1
Annemans, L; Ramaekers, D; Sermeus, W; Van Herck, P	1
Haxho, F; Neufeld, RJ; Szewczuk, MR	1

Reviews

1 review(s) available for oseltamivir and Breast Neoplasms

Article	Year
Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis. Oncotarget, 2016, Jun-28, Volume: 7, Issue:26 Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Survival; Disease Progression; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Female; Humans; Macrophages; Matrix Metalloproteinase 9; Mice; Mutation; Neoplasm Metastasis; Neoplasms; Neuraminidase; Oseltamivir; Ovarian Neoplasms; Receptor Protein-Tyrosine Kinases; Signal Transduction	2016

Article

Year

Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.

Oncotarget, 2016, Jun-28, Volume: 7, Issue:26

Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Survival; Disease Progression; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Female; Humans; Macrophages; Matrix Metalloproteinase 9; Mice; Mutation; Neoplasm Metastasis; Neoplasms; Neuraminidase; Oseltamivir; Ovarian Neoplasms; Receptor Protein-Tyrosine Kinases; Signal Transduction

2016

Other Studies

2 other study(ies) available for oseltamivir and Breast Neoplasms

Article	Year
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer. Drug design, development and therapy, 2020, Volume: 14 Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; CD24 Antigen; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hyaluronan Receptors; Metformin; Oseltamivir; Retinal Dehydrogenase; Spheroids, Cellular; Tamoxifen; Triple Negative Breast Neoplasms; Tumor Cells, Cultured	2020
Evidence-based health care policy in reimbursement decisions: lessons from a series of six equivocal case-studies. PloS one, 2013, Volume: 8, Issue:10 Topics: Antibodies, Monoclonal, Humanized; Aorta; Breast Neoplasms; Decision Making; Endovascular Procedures; Evidence-Based Practice; Habits; Health Policy; Humans; Insurance, Health, Reimbursement; Lobbying; Mass Media; Neutrons; Oseltamivir; Proton Therapy; Trastuzumab	2013

Article

Year

A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.

Drug design, development and therapy, 2020, Volume: 14

Topics: Aldehyde Dehydrogenase 1 Family; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; CD24 Antigen; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Hyaluronan Receptors; Metformin; Oseltamivir; Retinal Dehydrogenase; Spheroids, Cellular; Tamoxifen; Triple Negative Breast Neoplasms; Tumor Cells, Cultured

2020

Evidence-based health care policy in reimbursement decisions: lessons from a series of six equivocal case-studies.

PloS one, 2013, Volume: 8, Issue:10

Topics: Antibodies, Monoclonal, Humanized; Aorta; Breast Neoplasms; Decision Making; Endovascular Procedures; Evidence-Based Practice; Habits; Health Policy; Humans; Insurance, Health, Reimbursement; Lobbying; Mass Media; Neutrons; Oseltamivir; Proton Therapy; Trastuzumab

2013